Biosimilars Can Help Healthcare Systems Get Back On Track
Sandoz Europe Head Says COVID-19 Has Highlighted Supply Chain Resilience
Executive Summary
The head of Europe for Sandoz, Rebecca Guntern, has highlighted recent attention on supply-chain resilience during the pandemic, while talking about the key role of biosimilars in supporting post-COVID-19 healthcare systems.
You may also be interested in...
Guntern Takes Lead At Medicines For Europe
Sandoz’s Rebecca Guntern has been named as interim president of Medicines for Europe for a three-month term, after Teva’s Christoph Stoller stepped down at the end of his two-year tenure.
Kelix Strikes A Deal To Acquire 14 Oncology Injectables
Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.
Cipla And mAbxience Partner For Essential Biosimilars In South Africa
Cipla has partnered with mAbxience to supply oncology and respiratory-related biosimilars on the WHO model list of essential medicines to South Africa.